References
- Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411–5
- Inoue A, Yanagisawa M, Kimura S, et al. The human endothelin family–3 structurally and pharmacologically distinct isopeptides predicted by 3 separate genes. Proc Natl Acad Sci USA 1989; 86: 2863–7
- Brian S D, Crossman D C, Buckley TL. Endothelin-1: demonstration of potent effects on the microcirculation of humans and other species. J Cardiovasc Pharmacol 1989; 13: s147–s50, Suppl. 5
- Hirata Y, Yusimi H, Takata S, et al. Cellular mechanism of action by a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. Biochem Biophys Res Commun 1988; 154: 868–75
- Clarke J G, Benjamin N, Larkin S W, Webb D V, Davis G J, Maseri A. Endothelin is a potens long-lasting vasoconstrictor in man. Am J Physiol 1989; 257: H2033–5
- Carnacek P, Stewart DJ. Jmmunoreactive endothelin in human plasma: marked elevation in patients in cardiogenic shock. Biochem Biophys Res Commun 1989; 161: 562–7
- Davenport A P, Ashby M J, Easton P, et al. A sensitive radioimmunoassay measuring endo-thelin-like immunoreactivity in human plasma: comparison of levels in patients with essential hypertension and normotensive control subjects. ClinSci 1990; 78: 261–4
- Takahashi K, Ghatei M A, Lam H-C, O'Halloran D J, Bloom SR. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 1990; 33: 306–10
- Buckley M G, Sagnella G A, MacGregor GA. Plasma acidification increases atrial natriuretic peptide as measured by radioimmunoassay. Clin Chem 1987; 33: 104–5
- Ando K, Hirata Y, Scichiri M, Emori T, Marumo F. Presence of immunoreactive endothelin in human plasma. FEBS Lett 1989; 245: 164–6
- Totsune K, Mouri T, Takahashi K, et al. Detection of immunoreactive endothelin in plasma of hemodialysis patients. FEBS Lett 1989; 249: 239–42
- Saito Y, Nakao K, Itoh H, et al. Endothelin in human plasma and culture medium of aortic endothelial cells–detection and characterization with radioimmunoassay using monoclonal antibody. Biochem Biophys Res Commun 1989; 161: 320–6
- Suzuki N, Matsumoto H, Kitada C, Masaki T, Fujino M. A sensitive sandwich-enzyme immunoassay for human endothelin. J Immunol Meth 1989; 118: 245–50
- Wagner O F, Nowotny P, Vierhapper H, Waldhausl W. Plasma concentrations of endothelin in man: artcrio-venous differences and release during venous stasis. Eur J Clin Invest 1990; 20: 502–5
- Fyhrquist F, Saijonmaa O, Metsärinne K, Tikkanen I, Rosenlöf K, Tikkanen T. Raised plasma endothelin-1 concentration following cold pressor test. Biochem Biophys Res Commun 1990; 169: 217–21
- Kohno M, Yasunari K, Marakawa K-L, Yokokawa K. Plasma immunoreactive endothelin in essential hypertension. Am J Med 1990; 88: 614–8
- Emori T, Hirata Y, Ohta K, Shichiri M, Shimokado K, Fumiaki M. Concomitant secretion of big endothelin and its C-terminal fragment from human and bovine endothelial cells. Biochem Biophys Res Commun 1989; 162: 217–23
- Hartter E, Ludvik B, Schuller M, Lell B, Graf H. Big-endothelin in plasma of healthy persons, and of hemodialysis-patients. Abstract from XXVIIth Congress of the European Dialysis and Transplant Association–European Renal Association. ViennaAustria September, 1990; 137
- Shichiri M, Hirata Y, Ando K, et al. Plasma endothelin levels in hypertension and chronic renal failure. Hypertension 1990; 15: 493–6